This topic contains a solution. Click here to go to the answer

Author Question: Which of the following patient groups should be considered for lung expansion therapy using ... (Read 62 times)

bobbysung

  • Hero Member
  • *****
  • Posts: 519
Which of the following patient groups should be considered for lung expansion therapy using intermittent positive-pressure breathing (IPPB)?
 
  1. Patients with clinically diagnosed atelectasis who are not responsive to other therapies
  2. Patients at high risk for atelectasis who cannot cooperate with other methods
  3. All obese patients who have undergone abdominal surgery
  a. 1 and 2 only
  b. 2 and 3 only
  c. 1 and 3 only
  d. 1, 2, and 3

Question 2

Correct instruction in the technique of incentive spirometry should include which of the follow-ing?
 
  a. Use of accessory muscles at high inspira-tory flows
  b. Diaphragmatic breathing at slow to mod-erate flows
  c. Panting at volumes approaching total lung capacity
  d. Use of accessory muscles at low inspira-tory flows



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

amandanbreshears

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

ANS: A
IPPB may be useful for patients with clinically diagnosed atelectasis not responsive to other therapies, such as incentive spirometry and chest physiotherapy. In addition, IPPB may be useful for patients who are at high risk for atelectasis and not able to cooperate with more simple tech-niques such as IS.

Answer to Question 2

ANS: B
Correct technique calls for diaphragmatic breathing at slow-to-moderate inspiratory flows.





 

Did you know?

Vaccines cause herd immunity. If the majority of people in a community have been vaccinated against a disease, an unvaccinated person is less likely to get the disease since others are less likely to become sick from it and spread the disease.

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

There are more bacteria in your mouth than there are people in the world.

For a complete list of videos, visit our video library